This study evaluates how genetics may influence cancer cachexia, weight loss that can occur from cancer treatment in patients with pancreatic cancer that has locally advanced or spread (metastasized) and is not currently resectable (able to be removed) by surgery.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT05376592.
Locations matching your search criteria
United States
North Carolina
Charlotte
Carolinas Medical Center/Levine Cancer InstituteStatus: Active
Contact: Kunal C. Kadakia
Phone: 980-442-2361
PRIMARY OBJECTIVE:
I. Evaluate the association between CC (as defined as weight loss ≥ 5% of body weight within 3 months of diagnosis) and each single nucleotide polymorphism (SNP) in genes linked to inflammation and muscle regulation.
OUTLINE: This is an observational study.
Patients undergo blood and/or buccal swab sample collection and have their medical records reviewed on study.
Trial PhaseNo phase specified
Trial Typebasic science
Lead OrganizationWake Forest University Health Sciences
Principal InvestigatorKunal C. Kadakia
